Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pendyala

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumorsP J Creaven, L Pendyala, N J Meropol, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809)P J Creaven, S Madajewicz, J W Cowens, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 2006
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survivalL Leichman, D Lawrence, C G Leichman, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
S-phase modulation by irinotecan: pilot studies in advanced solid tumorsN Ramnath, N Khushalani, K Toth, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumorsP J Creaven, L Pendyala, N J Meropol, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809)P J Creaven, S Madajewicz, J W Cowens, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 2006
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survivalL Leichman, D Lawrence, C G Leichman, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
S-phase modulation by irinotecan: pilot studies in advanced solid tumorsN Ramnath, N Khushalani, K Toth, et al.
Pageof 6